Romaguera, R., Salinas, P., Gomez-Lara, J., Brugaletta, S., Gómez-Menchero, A., Romero, M. A., García-Blas, S., Ocaranza, R., Bordes, P., Kockar, M. J., Salvatella, N., Jiménez-Díaz, V. A., Alameda, M., Trillo, R., Lee, D. H., Martín, P., López-Benito, M., Freites, A., Pascual-Tejerina, V., Hernández-Hernández, F., Blanco, B. G. d., Mohandes, M., Bosa, F., Pinar, E., Roura, G., Comin-Colet, J., Fernández-Ortiz, A., Macaya, C., Rossello, X., Sabate, M., Pocock, S. J., Gómez-Hospital, J. A., & , (2022). amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial. European heart journal, 43, 1320–1330. http://access.bl.uk/ark:/81055/vdc_100153022147.0x000050